Gossamer Bio, Inc.
GOSS
Revenue
95.84M
▲95.84M∞%
12 Months ChangeAssets
373.45M
▲114.09M▲43.99%
3 Months ChangeLiabilities
291.92M
▲59.28M▲25.48%
3 Months ChangeFree Cash Flow
-52.99M
▲651.00k▲1.21%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-09-13
Form 8-K
ID: 0001728117-24-000088
2024-08-12
Form 8-K
ID: 0001728117-24-000086
2024-08-12
Form 10-Q
ID: 0001728117-24-000085
2024-07-18
Form 8-K
ID: 0001728117-24-000080
2024-06-10
Form 8-K
ID: 0001728117-24-000069
2024-05-24
Form 8-K
ID: 0001728117-24-000059
2024-05-07
Form 8-K
ID: 0001728117-24-000057
2024-05-07
Form 10-Q
ID: 0001728117-24-000056
2024-05-06
Form 8-K
ID: 0001728117-24-000052
2024-03-12
Form 8-K
ID: 0001728117-24-000024